Master India’s Updated GMP Standards with Expert-Led Guidance
At Indivirtus Healthcare Services Pvt. Ltd., our Revised Schedule M training program equips pharmaceutical teams with comprehensive knowledge of the 2024 amendments. Designed to ensure regulatory alignment, our training covers key changes, documentation, implementation strategies, and audit preparedness to meet India’s updated GMP expectations.
Our training program provides an in-depth understanding of the 2024 Revised Schedule M amendments, focusing on updated provisions, enhanced documentation, quality control requirements, and practical strategies for GMP compliance in pharmaceutical manufacturing.
Compliance with Revised Schedule M is essential for ensuring product quality, patient safety, and regulatory adherence in India, reducing the risk of non-compliance during inspections and supporting market approval.
As a trusted CRO, Indivirtus Healthcare Services delivers expert-led training to empower pharmaceutical teams, ensuring audit-ready operations and seamless alignment with India’s updated regulatory standards.
At Indivirtus Healthcare Services, our Revised Schedule M training is led by seasoned regulatory experts and auditors who bring deep regulatory expertise to every session. We provide a detailed exploration of the 2024 amendments, covering updated provisions, enhanced documentation, and quality control requirements. Our program includes practical implementation strategies and a mock audit simulation to ensure your team is fully prepared for regulatory inspections.
Our approach emphasizes actionable insights, combining interactive workshops, real-world case studies, and tailored guidance to align your operations with India’s GMP standards, fostering compliance and operational excellence.
Training Certificate: Official certification recognizing completion of Revised Schedule M training.
Change Impact Matrix: Detailed analysis of the 2024 amendments and their impact on operations.
Implementation Toolkit: Practical resources for adopting updated GMP requirements.
Mock Audit Feedback Report: Comprehensive feedback from simulated audit exercises.
Regulatory Reference Guides: Supplemental materials to support ongoing compliance.
Our Revised Schedule M training aligns with India’s updated regulatory framework, ensuring your team is equipped to meet statutory requirements and maintain audit-ready operations. By adhering to the latest guidelines, we deliver training that supports compliance with Indian and global pharmaceutical standards.
Our Revised Schedule M training is essential for pharmaceutical manufacturers seeking to align with India’s 2024 GMP amendments. The program is ideal for teams preparing for regulatory inspections, implementing new documentation processes, or enhancing quality control systems. Key use cases include ensuring compliance during facility upgrades, supporting new product launches, and preparing for CDSCO audits to achieve market compliance.
Indivirtus Healthcare Services is a trusted partner for pharmaceutical manufacturers, delivering expert-led Revised Schedule M training backed by certified regulatory experts with extensive Indian and global experience. Our programs ensure scientifically defensible outcomes, rapid delivery, and strict confidentiality to protect your proprietary information.
With a commitment to industry best practices, we empower your team with the knowledge and tools to achieve regulatory success and operational excellence in India’s evolving pharmaceutical landscape.
The training focuses on key changes in the 2024 Revised Schedule M, including updated GMP requirements, documentation practices, and audit expectations.
QA/QC heads, manufacturing supervisors, regulatory affairs professionals, and senior management responsible for GMP compliance should attend.
Yes, the training includes a realistic mock audit to evaluate your team’s preparedness and identify improvement areas.
Yes, we provide an implementation roadmap and a change impact matrix to support adoption of Revised Schedule M in your facility.
Yes, participants receive a certificate upon successful completion of the Revised Schedule M training module.
Our training covers the 2024 amendments to Schedule M, including updated GMP provisions, enhanced documentation, quality control requirements, implementation strategies, and a mock audit simulation to ensure regulatory preparedness.
This training is ideal for pharmaceutical professionals in manufacturing, quality assurance, regulatory affairs, or compliance roles, particularly those preparing for CDSCO inspections or aligning with India’s updated GMP standards.
Our program aligns with Revised Schedule M (2024), Drugs and Cosmetics Act & Rules, WHO GMP Guidelines, and ICH Q10, equipping your team with the knowledge to meet India’s regulatory requirements and ensure audit readiness.
Participants receive a training certificate, a change impact matrix, an implementation toolkit, a mock audit feedback report, and regulatory reference guides to support ongoing compliance.
Yes, our training is customized based on your facility’s operational needs, focusing on specific processes like manufacturing, documentation, or quality control to ensure practical and relevant outcomes.
Yes, we offer flexible delivery options, including on-site, virtual, and hybrid formats, to accommodate your team’s preferences and ensure seamless learning experiences.